I had to try it for myself, even though I was still a bit sceptical, I needed to know if it actually worked
Cochrane Database of Systematic Reviews
Patients receiving semaglutide (0.5 or 1.0 mg) for 104 weeks demonstrated a significantly higher risk of diabetic retinopathy complications, including vitreous hemorrhage, blindness, or required procedural treatment compared to those receiving placebo (HR, 1.76
It is perhaps too simple of an explanation to think weight is a key factor that is solely solvable by GLP-1 agonists, says Le
Public health initiatives, favorable reimbursement schemes, and widespread clinical research support market potential
As a psychiatrist, your DEA registration and state medical license allow you to prescribe: FDA-approved weight-loss medications (Wegovy, Saxenda, Contrave, Qsymia) Off-label GLP-1s (though some states like Mississippi have banned off-label use more below) Controlled substances for weight loss (phentermine, etc.) where not prohibited by state law No additional certification is legally required to prescribe obesity drugs